Book appointment
Book appointment
Untitled design

Introducing Rhenium SCT®: A Non-Surgical Skin Cancer Treatment Now Available in New Zealand

A New Option for Skin Cancer Care in Hawke’s Bay

Skin cancer remains one of New Zealand’s most significant health concerns, with some of the highest rates of non-melanoma skin cancer (NMSC) in the world. The need for safe, effective and patient‑centred treatment options continues to grow.

At Canopy Imaging in Hawke’s Bay, we are proud to introduce Rhenium SCT® (Skin Cancer Therapy) a breakthrough in skin cancer care now available for the first time in New Zealand.

We have already successfully treated our first patients, marking an important milestone for both our clinic and New Zealanders. 

What Is Rhenium SCT®?Rhenium SCT® is a non-invasive, single-session treatment designed for superficial (less than 3mm deep) non-melanoma skin cancers, including:

  • Basal Cell Carcinoma (BCC)
  • Squamous Cell Carcinoma (SCC)

This advanced therapy uses a radiotherapeutic paste applied via a protective foil placed directly over the lesion. It delivers a precisely controlled dose of beta radiation, targeting cancer cells while minimising exposure to surrounding healthy tissue.

Key Benefits of Rhenium SCT®

  • Non-surgical skin cancer treatment
  • Single-session therapy (30–180 minutes)
  • Painless procedure
  • Minimal impact on surrounding tissue
  • Excellent for cosmetically sensitive areas
  • No stitches or extended recovery time

Who Is This Treatment Suitable For?Rhenium SCT® may be particularly suitable for patients who:

  • Have lesions requiring complex surgical procedures
  • Are not ideal surgical candidates due to age or medical conditions
  • Lesions in cosmetically sensitive areas (nose, ears, lips, face)
  • Have had multiple procedures in the same area
  • Have multiple lesions

A Precision Approach to Skin Cancer Treatment

Because the radiation penetrates only a few millimetres into the skin, Rhenium SCT® delivers highly targeted treatment. This precision helps preserve healthy tissue while effectively treating cancerous cells.

“Rhenium SCT® allows us to treat certain skin cancers in a highly targeted way. For lesions in cosmetically sensitive areas or in patients who may not be ideal surgical candidates, this therapy provides an effective alternative with excellent outcomes.”

Advancing Skin Cancer Care in New Zealand

The introduction of Rhenium SCT® reflects a global shift toward minimally invasive cancer treatments that prioritise:

  • Patient comfort
  • Faster recovery
  • Cosmetic outcomes
  • Quality of life

Now available at Canopy Imaging Hawke’s Bay, this cutting-edge treatment provides patients across New Zealand access to the next generation of non-surgical skin cancer care.